Shanghai Pharmaceutical Group Co. Ltd.
Company Snapshot
Company Overview
Founded in 1994 and headquartered in Shanghai, China, Shanghai Pharmaceuticals Holding is a global pharmaceutical company engaged in the development, manufacturing and marketing of pharmaceutical products. The company commercializes more than 700 drug varieties of drugs on a global basis, covering more than 20,000 healthcare institutions in different parts of the world.
Shanghai Pharmaceuticals promotes the fundamental beliefs of “development, integrity, cooperation, inclusion, responsibility,” and it is committed to improving the health and quality of life of individuals through the manufacturing and supply of better therapeutics than are currently available. The company is committed to providing effective therapeutic medicines for anticancer and immunoregulation, including cardiovascular system, serious chronic disease, metabolism and anti-infection. Its key products include Feng Tingxin, Nuoxin Kang and Hydroxychloroquine sulfate tablets.
Shanghai Pharmaceutical’s R&D area aims the company’s efforts toward making high-quality drugs. Four of its products that have successfully passed consistency evaluation are: fluoxetine hydrochloride capsules, metformin hydrochloride sustained-release tablets, hydrochlorothiazide tablets and captopril tablets. Shanghai Pharmaceuticals has more than 32 products whose specifications completed the BioEquivalency (BE) test and were submitted to the National Medical Products Administration (NMPA) in 2021. These include levonorgestrel tablets, ibuprofen sustained-release capsules and duloxetine hydrochloride enteric-coated capsules. Using mature hematoma CAR-T, the company engages in cellular therapy research on solid tumor CAR-T at the SPH Biotherapeutics Center.
Shanghai Pharmaceuticals has expanded its R&D ventures in consistency assessments to completely exploit the newly regulated market and to provide affordable pharmaceutical options to patients.
Financial Highlights (FY 2025)
This information is available for BCC Research members only.
Shanghai Pharmaceutical Group Co. Ltd. In Reports
Shanghai Pharmaceutical Group Co. Ltd. In News
Company's Business Segments
- Main Operating Activities : This segment includes R&D Innovation, Lean Manufacturing, Distribution Services, Retail Services, Field expansion
- Other Operating Activities : This segment includes Finance income, Other sources of Income.
Applications/End User Industries
- Pharmaceutical
- Healthcare
- Innovative Drug
- Nephropathy
- Myasthenia
- Pemphigus
- Clinical Applications
- Psychiatric
- Cardiovascular
- Neurological
- Life Sciences